Acadia Healthcare (NASDAQ:ACHC - Get Free Report) had its price objective decreased by Royal Bank of Canada from $94.00 to $64.00 in a report released on Monday,Benzinga reports. The firm presently has an "outperform" rating on the stock. Royal Bank of Canada's target price would suggest a potential upside of 72.37% from the company's current price.
Several other research analysts also recently weighed in on ACHC. KeyCorp initiated coverage on Acadia Healthcare in a research note on Friday, October 11th. They set a "sector weight" rating for the company. Barclays decreased their price target on shares of Acadia Healthcare from $83.00 to $76.00 and set an "overweight" rating on the stock in a research note on Monday, September 30th. Cantor Fitzgerald reiterated a "neutral" rating and set a $90.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft raised their target price on Acadia Healthcare from $70.00 to $75.00 and gave the company a "hold" rating in a research report on Friday, August 2nd. Finally, StockNews.com raised Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Thursday. Five analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, Acadia Healthcare has an average rating of "Moderate Buy" and an average target price of $83.33.
View Our Latest Stock Report on ACHC
Acadia Healthcare Stock Down 1.8 %
ACHC stock traded down $0.69 on Monday, hitting $37.13. 1,250,346 shares of the company's stock were exchanged, compared to its average volume of 1,004,496. The firm has a 50 day moving average price of $57.27 and a two-hundred day moving average price of $65.34. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. Acadia Healthcare has a 12-month low of $36.50 and a 12-month high of $87.77. The stock has a market cap of $3.45 billion, a P/E ratio of 12.17, a price-to-earnings-growth ratio of 1.68 and a beta of 1.33.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. During the same period in the prior year, the firm earned $0.91 EPS. The business's revenue for the quarter was up 8.7% on a year-over-year basis. As a group, equities research analysts expect that Acadia Healthcare will post 3.38 EPS for the current fiscal year.
Hedge Funds Weigh In On Acadia Healthcare
Several large investors have recently made changes to their positions in ACHC. Blue Trust Inc. lifted its stake in Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company's stock worth $36,000 after purchasing an additional 248 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company's stock valued at $42,000 after buying an additional 241 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new position in Acadia Healthcare during the 2nd quarter worth about $59,000. Covestor Ltd boosted its holdings in Acadia Healthcare by 834.4% during the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company's stock valued at $72,000 after acquiring an additional 1,018 shares during the period. Finally, DekaBank Deutsche Girozentrale purchased a new stake in Acadia Healthcare during the third quarter worth about $86,000.
About Acadia Healthcare
(
Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Read More
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.